PRCS (PRCS) Stock Price & Analysis
PRCS (PRCS) rose 0.44% to USD 27.91 as of July 25, 2026 at 19:41 UTC, according to Nexqual real-time market data.
PRCS last closed at USD 27.79; the session ranged USD 27.81–27.96 on volume of 4,345 shares. Market capitalization is —, with a 52-week range of USD 24.22–29 (NYQ). Source: Nexqual, July 25, 2026 at 19:41 UTC.
Key Statistics (as of July 25, 2026 at 19:41 UTC)
| Price | USD 27.91 |
|---|---|
| Change | ▲ 0.44% (up) |
| Previous Close | USD 27.79 |
| Open | USD 27.8 |
| Day Range | USD 27.81 – 27.96 |
| 52-Week Range | USD 24.22 – 29 |
| Volume | 4,345 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (PRCS)
Nexqual's technical model rates PRCS "SELL" based on 2 bullish and 4 bearish signals across 125 daily candles, as of July 25, 2026 at 19:41 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 45.52 (neutral) |
| vs SMA50 | Below (USD 27.99) |
| MACD | 0.02 (positive) |
Financial Health Score (PRCS)
Nexqual rates PRCS's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 19:41 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MEDX | Horizon Kinetics Medical ETF | USD 35.49 | ▲ 1.41% |
| GNTA | Genenta Science S.p.A. | USD 1.59 | ▼ 3.05% |
| NTII | NEUROBIOLOGICAL TECHNOLOGIES IN | USD 0 | ▲ 0% |
| QLTI | GMO International Quality ETF | USD 26.23 | ▼ 0.82% |
| IDEV | iShares Core MSCI International | USD 88.99 | ▼ 0.76% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 19:41 UTC. This page is informational and not investment advice.